A detailed history of Keebeck Alpha, LP transactions in Penumbra Inc stock. As of the latest transaction made, Keebeck Alpha, LP holds 1,066 shares of PEN stock, worth $323,125. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,066
Holding current value
$323,125
% of portfolio
0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$190.97 - $253.66 $203,574 - $270,401
1,066 New
1,066 $253,000
Q1 2024

May 13, 2024

BUY
$220.09 - $273.15 $187,296 - $232,450
851 Added 69.87%
2,069 $461,000
Q4 2023

Feb 12, 2024

BUY
$181.44 - $260.22 $68,765 - $98,623
379 Added 45.17%
1,218 $306,000
Q3 2023

Nov 02, 2023

BUY
$240.69 - $338.77 $201,938 - $284,228
839 New
839 $202,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $11.5B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.